BacMam recombinant baculovirus in transporter expression: A study of BCRP and OATP1B1

Protein Expression and Purification

Volumn 47, Issue 2, 2006, Pages 591-598

  Hassan, Namir J ^a   Pountney, David J ^a   Ellis, Catherine ^b   Mossakowska, Danuta E ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

ABCG2; ADME; BacMam; BCRP; Efflux transporter; Influx transporter; MXR; OATP C; OATP1B1; OATP2; Pharmacokinetics; SLC21A6

Indexed keywords

ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; ACRIDINE DERIVATIVE; ELACRIDAR; INDOLE DERIVATIVE; ORGANIC ANION TRANSPORTER; SLCO1B1 PROTEIN, HUMAN; TETRAHYDROISOQUINOLINE DERIVATIVE; TRYPTOQUIVALINE; TUMOR PROTEIN;

ANIMAL; ARMYWORM; ARTICLE; BACULOVIRUS; BIOSYNTHESIS; CELL MEMBRANE; CELL STRAIN COS1; CERCOPITHECUS; CYTOLOGY; DRUG ANTAGONISM; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; SWINE; TUMOR CELL LINE;

ACRIDINES; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BACULOVIRIDAE; CELL LINE, TUMOR; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; INDOLES; NEOPLASM PROTEINS; ORGANIC ANION TRANSPORTERS; SPODOPTERA; SWINE; TETRAHYDROISOQUINOLINES; TRANSDUCTION, GENETIC;

MAMMALIA;

EID: 33646566362     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.12.008     Document Type: Article

References (36)

1. Roberts S.A. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics. Xenobiotica 31 (2001) 557-589
2. Ayrton A., and Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31 (2001) 469-497
3. Mizuno N., Niwa T., Yotsumoto Y., and Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev. 55 (2003) 425-461
4. Mizuno N., and Sugiyama Y. Drug transporters: their role and importance in the selection and development of new drugs. Drug Metab. Pharmacokinet. 17 (2002) 93-108
5. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., and Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 95 (1998) 15665-15670
6. Knutsen T., Rao V.K., Ried T., Mickley L., Schneider E., Miyake K., Ghadimi B.M., Padilla-Nash H., Pack S., Greenberger L., Cowan K., Dean M., Fojo T., and Bates S. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Genes Chromosomes Cancer 27 (2000) 110-116
7. Litman T., Brangi M., Hudson E., Fetsch P., Abati A., Ross D.D., Miyake K., Resau J.J., and Bates S.E. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell Sci. 113 (2000) 2011-2021
8. Rabindran S.K., He H., Singh M., Brown E., Collins K.I., Annable T., and Greenberger L.M. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res. 58 (1998) 5850-5858
9. Miyake K., Mickley L., Litman T., Zhan Z., Robey R., Cristensen B., Brangi M., Greenberger L., Dean M., Fojo T., and Bates S.E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells. Cancer Res. 59 (1999) 8-13
10. Ross D.D., Karp J.E., Chen T.T., and Doyle L.A. Expression of breast cancer resistance protein in blast cells from patients with acute leukaemia. Blood 96 (2000) 365-368
11. Yang C.H., Schneider E., Kuo M.L., Volk E.L., Rocchi E., and Chen Y.C. BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochem. Pharmacol. 60 (2000) 831-837
12. Chan L.M., Lowes S., and Hirst B.H. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 21 (2004) 25-51
13. Burger H., van Tol H., Brok M., Wiemer E.A., de Bruijn E.A., Guetens G., de Boeck G., Sparreboom A., Verweij J., and Nooter K. Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps. Cancer Biol. Ther. 4 (2005)
14. Burger H., van Tol H., Boersma A.W., Brok M., Wiemer E.A., Stoter G., and Nooter K. Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. Blood 104 (2004) 2940-2942
15. Nishizato Y., Ieiri I., Suzuki H., Kimura M., Kawabata K., Hirota T., Takane H., Irie S., Kusuhara H., Urasaki Y., Urae A., Higuchi S., Otsubo K., and Sugiyama Y. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin. Pharmacol. Ther. 73 (2003) 554-565
16. Ishizuka H., Konno K., Naganuma H., Nishimura K., Kouzuki H., Suzuki H., Stieger B., Meier P.J., and Sugiyama Y. Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. J. Pharmacol. Exp. Ther. 287 (1998) 37-42
17. Rippin S.J., Hagenbuch B., Meier P.J., and Stieger B. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology 33 (2001) 776-782
18. Honjo Y., Hrycyna C.A., Yan Q.W., Medina-Perez W.Y., Robey R.W., van de Laar A., Litman T., Dean M., and Bates S.E. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res. 61 (2001) 6635-6639
19. Robey R.W., Honjo Y., Morisaki K., Nadjem T.A., Runge S., Risbood M., Poruchynsky M.S., and Bates S.E. Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br. J. Cancer 89 (2003) 1971-1978
20. Mohrmann K., van Eijndhoven M.A., Schinkel A.H., and Schellens J.H. Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2). Cancer Chemother. Pharmacol. 56 (2005) 344-350
21. Takada T., Suzuki H., and Sugiyama Y. Characterization of polarized expression of point- or deletion-mutated human BCRP/ABCG2 in LLC-PK1 cells. Pharm. Res. 22 (2005) 458-464
22. Ozvegy C., Litman T., Szakacs G., Nagy Z., Bates S., Varadi A., and Sarkadi B. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem. Biophys. Res. Commun. 285 (2001) 111-117
23. Kost T.A., and Condreay J.P. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol. 20 (2002) 173-180
24. Kost T.A., Condreay J.P., and Jarvis D.L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol. 23 (2005) 567-575
25. Pfohl J.L., Worley III J.F., Condreay J.P., An G., Apolito C.J., Kost T.A., and Truax T.F. Titration of KATP channel expression in mammalian cells utilizing recombinant baculovirus transduction. Receptors Channels 8 (2002) 99-111
26. Clay W.C., Condreay J.P., Moore L.B., Weaver S.L., Watson M.A., Kost T.A., and Lorenz J.J. Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells. Assay Drug Dev. Technol. 1 (2003) 801-810
27. Boudjelal M., Mason S.J., Katso R.M., Fleming J.M., Parham J.H., Condreay P.J., and Cairns W. The application of bacmam technology in nuclear receptor drug discovery. Biotechnol. Ann. Rev. 11 (2005) 101-125
28. Ames R., Fornwald J., Nuthulaganti P., Trill J., Foley J., Buckley P., Kost T., Wu Z., and Romanos M. BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery. Receptors Channels 10 (2004) 99-107
29. Condreay J.P., Witherspoon S.M., Clay C.M., and Kost T.A. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. Sci. USA 96 (1999) 127-132
30. O'Reilly D.R., Miller L.K., and Luckow V.A. Baculovirus Expression Vectors: A Laboratory Manual (1994), Oxford University Press, New York
31. de Bruin M., Miyake K., Litman K., Robey R., and Bates S.E. Reversal of resistance by GF120918 in cell lines expressing the half-transporter, MXR. Cancer Lett. 146 (1999) 117-126
32. Robey R.W., Honjo Y., van de Laar A., Miyake K., Regis J.T., Litman T., and Bates S.E. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim. Biophys. Acta 1512 (2001) 171-182
33. Breen C.M., Sykes D.B., Baehr C., Fricker G., and Miller D.S. Fluorescein-methotrexate transport in rat choroid plexus analyzed using confocal microscopy. Am. J. Physiol. Renal Physiol. 287 (2004) 562-569
34. Cui Y., Konig J., Leier I., Buchholz U., and Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J. Biol. Chem. 276 (2001) 9626-9630
35. Cui Y., Konig J., and Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol. Pharmacol. 60 (2001) 934-943
36. Sasaki M., Suzuki H., Ito K., Abe T., and Sugiyama Y. Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and multidrug resistance-associated protein 2 (MRP2/ABCC2). J. Biol. Chem. 277 (2002) 6497-6503